期刊文献+

sCR1在原核中表达、纯化、复性及活性鉴定 被引量:6

Expression, purification, refolding and its biologic activity research of sCR1 in prokaryon
下载PDF
导出
摘要 目的采用原核表达载体pET28a在E.coli BL21(DE3)中获得高表达、高活性的重组人sCR1融合蛋白。方法从人外周血中提取总RNA,应用RT-PCR获得人sCR1全长cDNA,将其克隆入原核表达载体pET28a中,构建含人sCR1的重组质粒(pET28a-sCR1),经测序鉴定正确,转化入E.coli BL21(DE3)中,经IPTG诱导,表达产物经SDS-PAGE分析和Western blot鉴定,通过Ni2+-NTA agarose亲和层析纯化后进行复性及生物学活性鉴定。结果获得原核表达载体pET28a-sCR1,经PCR鉴定及测序鉴定,得到重组E.coli BL21(DE3)克隆菌株,经IPTG诱导含有pET28a-sCR1的E.coli BL21(DE3)克隆菌,表达出重组人sCR1融合蛋白。此蛋白在SDS-PAGE上表现为Mr大于29000的蛋白区带,在Western blot分析中可被sCR1的CD35单克隆单抗体(mAb)识别。经Ni2+-NTA agarose亲和层析纯化、复性后得到高纯度的sCR1融合蛋白表达及较高的生物学活性。结论人sCR1融合蛋白在E.coli BL21(DE3)表达系统中的高水平表达,并且有与人体天然蛋白相同的抗原性及其生物学活性。 Objective To obtain highly expressed, highly actived recombinant human sCR1 fusion proteins in E. coil BL21 (DE3) using prokaryotic expression vector pET28a. Methods Total human RNA was extracted from peripheral blood. The full length eDNA of human sCR1 gene was obtained using RT- PCR and them, cloned into prokaryotic expression vector pET28a to construct the recombinant plasmid p ET28a-sCR1 containing human sCRI. After identified by DNA sequencing, the recombinant plasmid pP1C9k-sCR1 was transformed into E. coil BL21 (DE3). After 1PTG induction, the expressed protein products were verified by SDS-PAGE and Western blotting, purified by Ni2+-NTA agarose affinity chromatography, refolding and its biologic activity was identified. Results The obtained prokaryotic expression vector pET28a -sCR1 was identified by PCR and DNA sequencing to get E. coli BL21(DE3) clone strain. The recombinant human sCRI fusion protein was expressed by E. coli BL21 (DE3) clone strain containing pET28a-sCRI induced by IPTG. It was a protein band about Mr above 29 000 in gel, which could be identified by CD35 of anti-sCRl protein monoclonal antibody with Western blotting technique. The highly purified sCR1 fusion protein and its biologic activity were detected obtained by Ni2+NTA agarose affinity chromatography and refolding. Conclusion The recombinant human sCR1 fusion protein can be highly expressed in E. coil BL21 (DE3) expression system, which resembles the human natural protein's antigenicity and biologic activity.
机构地区 [ [
出处 《实用医药杂志》 2008年第8期970-973,977,共5页 Practical Journal of Medicine & Pharmacy
基金 济南军区重点课题(02Z27)
关键词 可溶性补体受体1型 原核表达载体 包涵体 纯化 复性 生物学活性 Soluble complement receptor type 1 Prokaryotic expression vector Inclusion body Purification Refolding Biologic activity
  • 相关文献

参考文献3

  • 1Weisman HF, Barrow T, Leppo MK, et al. Soluble human complement receptor type Ⅰ: in vivo inhibitor of complement suppressing postschemic myocardial infammation and necrosis. Science, 1990,249 (4965):146.
  • 2王广兰,宫璀璀,王文丽,张长远,王炳南,关晓峰,王轩,李璇.重组人sCR1在巴斯德毕赤酵母细胞中的表达、纯化及鉴定[J].细胞与分子免疫学杂志,2007,23(11):1066-1068. 被引量:12
  • 3朱忠勇.实用医学检验学[M].北京:人民卫生出版社,1991.940.

二级参考文献5

  • 1Weisman HF,Bartow T,Leppo MK,et al.Soluble human complement receptor type 1:in vivo inhibitor of complement suppressing postschemic myocardial infammation and necrosis[J].Science,1990,249(4965):146-151.
  • 2Mizuno M,Nishikawa K,Okada N,et al.Soluble complement receptor type1 protects rats from lethal shock induced by anti-crry antibody following lipopolysaccharide priming[J].Int Arch Allergy Immunol,2002,127(1):55-62.
  • 3Azimzadeh A,Zorn GL,Blair KS,et al.Hyperacute lung rejection in the pig-to-human model.2.synergy between soluble and membrane complement inhibition[J].Xenotransplantation,2003,10(2):120-131.
  • 4Daly R,Hearn MT.Expression of heterologous proteins in pichia pastoris:a useful experimental too in protein engineering and production[J].J Mol Recognit,2005,18(2):119-138.
  • 5Cos O,Ramón R,Montesinos JL,et al.Operational strategies,monitoring and control of heterologous protein production in the methylotrophic yeast pichia pastoris under different promoters[J].Microb Cell Fact,2006,5(1):17-19.

共引文献19

同被引文献42

  • 1史西志,毕燕会,周志刚.海带雄性配子体差异表达基因片段的克隆及筛选[J].水产学报,2005,29(5):666-669. 被引量:12
  • 2盛春泉,朱杰,张万年,徐辉,缪震元,姚建忠,张珉.N-肉豆蔻酰基转移酶家族的进化踪迹分析研究[J].药学学报,2007,42(2):157-165. 被引量:2
  • 3Makrids SC, Nygren PA, Andrews B, et al Extended in vivo half-life of human soluble complement receptor type 1 fused to a serm albuminbinding receptor [ J]. Pharmacol Exp Ther, 1996,277:534-542.
  • 4Noriyuki I, Hisamune K, Wang PC. Observation by election microscopy on recombinant soluble human complement receptor type 1 (sCR1) and is derivative, aglyco-sCR1, from CHO cells[J]. Enzymc and Microbial Technology, 2003, 33 (4) : 482-487.
  • 5Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing postschemic myocardial infammation and necrosis [ J ]. Science , 1990, 249 (4965) :146-151.
  • 6Makrids SC, Nygren PA, Andrews B, et al. Extended in vivo half- life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor[ J]. J Pharmacol Exp Ther, 1996,277 ( 1 ) : 534-542.
  • 7Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1 : in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis [ J ]. Science, 1990, 249 (4965) :146-151.
  • 8FAO. FAO yearbook. Fishery statistics aquaculture production[ C] // Food and Agriculture Organization of the United Nations, Rome. 2006,98( 2 ) : 1 - 199.
  • 9吴超元,索如瑛.形态、生殖和生活史[M]∥曾呈奎,吴超元(编著).海带养殖学.北京:科学出版社,1962:14-33.
  • 10Starr R C, Zeikus J A. UTEX-The culture collection of algae at the University of Texas at Austin [ J ]. Journal of Phycology, 1993,29( suppl. ) : 1 - 106.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部